Therefore, our finding that maternal probiotics increased luminal IgA levels means that maternal probiotic administration enhances intestinal mucosal immune function in the maternally separated rat model of IBS where there is a high risk of increased intestinal permeability [6], [7]. The gene discussed is CD79A; the disease is irritable bowel syndrome.